DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Scopolamine (Scopolamine) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Scopolamine life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Scopolamine side effects in male

Reported by a pharmacist from Denmark on 2012-07-24

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Off Label Use, Swollen Tongue

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Scopolamine

Other drugs received by patient: Acetaminophen



Possible Scopolamine side effects in male

Reported by a pharmacist from Denmark on 2012-06-22

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Off Label Use, Swollen Tongue

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Scopolamine



Possible Scopolamine side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-01

Patient: female, weighing 54.4 kg (119.7 pounds)

Reactions: Wrong Technique in Drug Usage Process, Abnormal Behaviour, Mental Status Changes, Amnesia, Hallucination, Logorrhoea

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Scopolamine



Possible Scopolamine side effects in male

Reported by a consumer/non-health professional from Germany on 2011-10-25

Patient: male

Reactions: Wrong Technique in Drug Usage Process, Paresis, Extrasystoles, Quality of Life Decreased, Pallor, Somnolence, Death, Poor Quality Sleep, Off Label Use, Fatigue, Oedema Peripheral, Respiratory Muscle Weakness, Sudden Onset of Sleep, Oxygen Saturation Decreased, Motor Dysfunction, General Physical Health Deterioration, Cognitive Disorder, Anxiety, Hypopnoea, Depressed Level of Consciousness, Mobility Decreased

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Scopolamine
    Dosage: 0.25 df, q72h
    Indication: Salivary Hypersecretion
    Start date: 2011-03-15

Scopolamine
    Dosage: 0.5 df, q72h
    Start date: 2011-03-14
    End date: 2011-03-14

Other drugs received by patient: Metoprolol Succinate; Levothyroxine Sodium; NON-Drug: Bandages

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017